RFA-HD-23-023: Pediatric Clinical Pharmacology Research Career Development Award (K12 Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.
National Institutes of Health offered grants of up to $275,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on December 6, 2022.
From the official notice on Grants.gov, last changed September 9, 2022. Checked November 7, 2026.
- Award ceiling$275,000
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeK12
- Clinical trialsNot allowed
- Funded byNICHD
- Median yearly award$294,144
- Typical project length5 years
- K12, Institutional Career Development Program. An institution's program that places early-career researchers in mentored career development. Other open K12 notices.
Projects funded under RFA-HD-23-023 were run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, 2 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-HD-23-023 in the NIH Guide.
Key dates
| Posted | September 9, 2022 |
|---|---|
| Deadline | December 6, 2022 |
| Archived by Grants.gov | January 11, 2023 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Is this a realistic fit?
- Projects NIH funded under this notice had a median yearly award of $294,144; it allows up to $275,000 per award.
- Most of the program's money (72% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that support mentored research and career development experiences for scholars pursuing clinical, translational, and/or basic research in pediatric therapeutics. This program constitutes a national network of mentors and scholars, in contrast to K12 programs that are based solely at a single applicant institution. The primary purpose of this FOA is to ensure that a pipeline of diverse and highly trained workforce is available in pediatric pharmacology-related clinical and biomedical fields that currently have a limited number of researchers. This FOA will support essential research career development opportunities and ensure protected time to pursue impactful research experiences for new faculty-level clinical pharmacologists, fostering the transition to productive highly skilled clinical pharmacologist investigators. This initiative proposes to expand and strengthen the community of clinical pharmacologist investigators engaged in pediatric clinical pharmacology research.
Funded under RFA-HD-23-023 so far
NIH funded 2 projects under RFA-HD-23-023 in fiscal 2023 to 2026, at 2 institutions. The median yearly award was $294,144.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| National Career Development Program for Researchers in Pediatric Clinical Pharmacology | Duke University | 2026 | $292,194 |
| Clinical Pharmacology K12 Training Program | Cincinnati Childrens Hosp Med Ctr | 2026 | $297,000 |
Who has won Child Health and Human Development Extramural Research grants before
From fiscal 2021 to 2025, Child Health and Human Development Extramural Research (93.865) awarded $6.0 billion across 6,026 grant awards, an average of $1.0 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Regents of the University of Michigan | Michigan | 167 | $178 million |
| The Johns Hopkins University | Maryland | 133 | $146 million |
| University of Washington | Washington | 114 | $131 million |
| Baylor College of Medicine | Texas | 116 | $124 million |
| The Leland Stanford Junior University | California | 104 | $116 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-HD-23-023 still open?
No. It closed on December 6, 2022.
Who can apply for Pediatric Clinical Pharmacology Research Career Development Award (K12 Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Pediatric Clinical Pharmacology Research Career Development Award (K12 Clinical Trial Not Allowed)?
Closed December 6, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $275,000 each.
Who has been funded under RFA-HD-23-023?
NIH RePORTER lists 2 projects funded under RFA-HD-23-023 in fiscal 2023 to 2026, at 2 institutions. The most were at Duke University, Cincinnati Childrens Hosp Med Ctr.
Who has won Child Health and Human Development Extramural Research grants before?
The largest recipients over five fiscal years were Regents of the University of Michigan, The Johns Hopkins University, University of Washington. The program made 6,026 awards worth $6.0 billion in that time.
Similar open grants
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
- R3PEATS Rigor Scholar Cohort Awards (K12)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
- Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)
- Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed)